[CAS NO. 1181081-71-9]  CLP257

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [1181081-71-9]

Distributor
Catalog
AS908352
Brand
Arctom Scientific
CAS
1181081-71-9

DESCRIPTION [1181081-71-9]

Overview

MDL-
Molecular Weight307.34
Molecular FormulaC14H14FN3O2S
SMILESO=C1N=C(N2CCCCN2)S/C1=C\C3=CC=C(F)C=C3O

For research use only. We do not sell to patients.

Summary

CLP257 is a selective K + -Cl cotransporter KCC2 activator with an EC 50 of 616 nM. CLP257 is inactive against NKCC1, GABAA receptors, KCC1, KCC3 or KCC4. CLP257 restores impaired Cl transport in neurons with diminished KCC2 activity. CLP257 alleviates hypersensitivity in rats with neuropathic pain. CLP257 modulates plasmalemmal KCC2 protein turnover post-translationally [1] [2] .


IC50 & Target

EC50: 616 nM (KCC2) [1]


In Vitro

There is no change in [Cl ] i in HEK293-cl cells when incubated with CLP257, indicating inactivity on NKCC1, KCC1, KCC3 or KCC4. Oocyte pre-incubation with CLP257 (200 nM) increases KCC2 transport activity by 61%, but causes no change in other CCCs. Functional, dose-dependent antagonism is also observed between CLP257 and the recently characterized KCC2 antagonist VU024055119. CLP257 (50 μM) provokes < 0.2% of the effect of 5 μM muscimol in CHO cells transduced with recombinant α1β2γ2 GABAA receptors, indicating negligible agonist activity of CLP257 on GABAA receptors [1] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.


In Vivo

CLP257 (100 mg/kg; intraperitoneal injection; adult male rats) treatment induced a significant increase in mechanical sensitivity [2] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Adult male rats (300 g) injected with Morphine [2]
Dosage: 100 mg/kg
Administration: Intraperitoneal injection
Result: Induced a significant increase in mechanical sensitivity.

Appearance

Solid


Shipping

Room temperature in continental US; may vary elsewhere.


Storage

Powder -20°C 3 years
4°C 2 years

* The compound is unstable in solutions, freshly prepared is recommended.


Solvent & Solubility

In Vitro:

DMSO : 17.86 mg/mL ( 58.11 mM ; Need ultrasonic)

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 3.2537 mL 16.2686 mL 32.5373 mL
5 mM 0.6507 mL 3.2537 mL 6.5075 mL
10 mM 0.3254 mL 1.6269 mL 3.2537 mL
* Please refer to the solubility information to select the appropriate solvent.
In Vivo:
  • 1.

    Add each solvent one by one: 10% DMSO >> 40% PEG300 >> 5% Tween-80 >> 45% saline

    Solubility: ≥ 1.79 mg/mL (5.82 mM); Clear solution

  • 2.

    Add each solvent one by one: 10% DMSO >> 90% corn oil

    Solubility: 1.79 mg/mL (5.82 mM); Clear solution; Need ultrasonic

* All of the co-solvents are available by MCE.